Skip to product information
1 of 4

Nexus Peptides

Cjc-1295 + Ipamorelin: 10mg*10 vials

Cjc-1295 + Ipamorelin: 10mg*10 vials

Regular price $329.99 USD
Regular price $439.99 USD Sale price $329.99 USD
Sale Sold out
Size
View full details

Product Description: CJC-1295 + Ipamorelin

Introduction:
CJC-1295 + Ipamorelin is a combination of two peptides commonly utilized in scientific research. This combination is often studied for its potential to impact various physiological processes. Researchers have been investigating the molecular interactions of these peptides, focusing on their roles in regulating certain aspects of metabolism and growth factor expression. This peptide blend, when used in laboratory settings, serves as a valuable research tool to explore the interactions of different biological systems.

What is CJC-1295 + Ipamorelin?
CJC-1295 is a synthetic peptide, specifically a Growth Hormone Releasing Hormone (GHRH) analog, while Ipamorelin is a selective Growth Hormone Secretagogue (GHS). The combination of these two peptides is believed to potentially work together to influence the secretion of growth hormone by stimulating the pituitary gland. CJC-1295 is known for its extended half-life, allowing for prolonged activity in the body, while Ipamorelin is a more selective compound that mimics ghrelin's effects, which may help in the modulation of growth hormone release.

Together, these peptides form a combination that is of interest to researchers exploring the regulation of growth hormone and related signaling pathways. This blend is often used in preclinical studies to investigate its potential effects on metabolism, growth factor expression, and the regulation of certain biological processes.

Potential Different Names:

  • CJC-1295 + Ipamorelin
  • CJC-1295 with Ipamorelin Blend
  • GHRH Analogue + Growth Hormone Secretagogue
  • CJC-1295/Ipamorelin Combo

Chemical Formula:

  • CJC-1295: C152H252N44O42
  • Ipamorelin: C38H49N9O5

Structure:
CJC-1295 is a large peptide with a complex structure consisting of a series of amino acids that mimic the action of growth hormone-releasing hormone (GHRH). This peptide has a modified structure designed to extend its half-life in circulation, which allows for prolonged action. Ipamorelin, on the other hand, is a smaller peptide composed of a sequence of amino acids that mimics the effects of ghrelin, a natural peptide involved in regulating hunger and growth hormone release. When combined, these two peptides may interact synergistically to potentially modulate the release of growth hormone in the body.

The structural composition of these peptides enables them to bind to specific receptors in the body, potentially influencing the secretion of growth hormone and other related pathways. Their ability to interact with growth hormone-releasing hormone (GHRH) receptors and ghrelin receptors may make them useful in preclinical research aimed at understanding the regulation of growth hormone secretion.

How Does it Work?
CJC-1295 + Ipamorelin works by mimicking natural processes in the body that regulate the release of growth hormone (GH). CJC-1295 acts as a GHRH analog, binding to GHRH receptors in the pituitary gland and stimulating the release of growth hormone. Due to its structural modifications, CJC-1295 has a prolonged half-life, meaning it remains active in the body for an extended period, thereby potentially prolonging its effects on GH secretion.

Ipamorelin works by mimicking the action of ghrelin, a hormone that plays a role in the regulation of appetite and growth hormone secretion. By binding to specific receptors in the pituitary gland, Ipamorelin may support the release of growth hormone. When combined with CJC-1295, the two peptides may have a synergistic effect, enhancing the stimulation of growth hormone release, which can be studied for various research purposes.

This combination of peptides is typically used in preclinical research to investigate the modulation of growth hormone secretion and the effects this may have on metabolism, tissue growth, and other biological processes.

Conclusion:
CJC-1295 + Ipamorelin is a combination of two peptides that are of great interest to the scientific community for their potential to influence growth hormone release. CJC-1295, a GHRH analog, and Ipamorelin, a ghrelin-like peptide, work together to modulate the secretion of growth hormone. This peptide blend is primarily used in research settings to explore its effects on metabolic processes, growth factor expression, and the regulation of various biological systems.

Disclaimer:
This product is intended for research purposes only and is not approved for human consumption or therapeutic applications. It should only be used in accordance with proper laboratory protocols and safety guidelines. Researchers are advised to comply with local regulations and safety standards when handling this peptide combination in experimental environments.